Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Insight Lifetech CoSHSE:688712 -0.09%31 Buyback Yield % is 0.00 as of Jul. 21, 2026. GuruFocus rates SHSE:688712 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 348 Medical Devices & Instruments companies, Insight Lifetech Co ranks worse than 287356.03% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Insight Lifetech Co Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Insight Lifetech Co's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688712 vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Insight Lifetech Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insight Lifetech Co Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Insight Lifetech Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Insight Lifetech Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insight Lifetech Co (SHSE:688712) has a Buyback Yield % of 0.00 as of Jul. 21, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Insight Lifetech Co and its competitors. According to the industry distribution chart, Insight Lifetech Co ranks #999999 out of 348 companies in the Medical Devices & Instruments industry.
Is Insight Lifetech Co's Buyback Yield % too high?
Insight Lifetech Co's current Buyback Yield % is 0.00. Based on the distribution chart, Insight Lifetech Co ranks #999999 out of 348 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Insight Lifetech Co has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Insight Lifetech Co's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Insight Lifetech Co ranks #999999 out of 348 companies for Buyback Yield %. This places Insight Lifetech Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Insight Lifetech Co and its competitors. Insight Lifetech Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insight Lifetech Co stock overvalued right now?
Insight Lifetech Co (SHSE:688712) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Insight Lifetech Co's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Insight Lifetech Co (SHSE:688712), the current Buyback Yield % is 0.00 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressMinzhi Street, Hongrongyuan North Station Center, Tower A 2102, North Station Community, Longhua District, Guangdong Province, Shenzhen, CHN, 518000
Insight Lifetech Co Ltd is a medtech company. It is engaged in the research and development, production, and sale of medical devices used in the diagnosis and treatment of cardiovascular diseases. The company's core products are the TruePhysio pressure microcatheter and VivoCardio FFR system.
31GF Score
Get the complete analysis for SHSE:688712
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688712 has been successfully added to your 
